lobbying_activities: 3489086

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3489086	d6cd4606-7eac-4a0c-93a7-685b94feb79b	Q4	PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION	401103605	PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION	2025	fourth_quarter	PHA	Discussed issues related to onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, workforce development, and potential impact of tariffs on domestic biopharmaceutical manufacturing.	Bureau of Industry and Security (BIS),Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE		50000	0	0	2026-01-16T12:43:30-05:00